Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bernstein

Showing results (1001-1010 of 1,085) with videos related to

Pageof 109
Sort By:
Breast Cancer Research and Treatment|February 6, 2010
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding, Jonine L Bernstein, Bryan M Langholz, et al.
Breast Cancer Research : BCR|November 18, 2011
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudySharon N Teraoka, Jonine L Bernstein, Anne S Reiner, et al.
Annals of Surgical Oncology|May 25, 2016
Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology GroupNajat C Daw, Nadia N Laack, Elizabeth J McIlvaine, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 3, 2014
A research agenda for gender and substance use disorders in the emergency departmentEsther K Choo, Gillian Beauchamp, Francesca L Beaudoin, et al.
Cardio-Oncology (London, England)|March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology GroupLisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
Human Mutation|January 28, 2010
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE studyAke Borg, Robert W Haile, Kathleen E Malone, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE studyMarilyn Stovall, Susan A Smith, Bryan M Langholz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
GLIOGENE an International Consortium to Understand Familial GliomaBeatrice Malmer, Phyllis Adatto, Georgina Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2Kathleen E Malone, Colin B Begg, Robert W Haile, et al.
Journal of the National Cancer Institute|December 27, 2007
Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology StudyLisbeth Bertelsen, Leslie Bernstein, Jørgen H Olsen, et al.
Pageof 109

Showing results (1001-1010 of 1,085) with videos related to

Sort By:
Pageof 109
Breast Cancer Research and Treatment|February 6, 2010
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerKerryn W Reding, Jonine L Bernstein, Bryan M Langholz, et al.
Breast Cancer Research : BCR|November 18, 2011
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudySharon N Teraoka, Jonine L Bernstein, Anne S Reiner, et al.
Annals of Surgical Oncology|May 25, 2016
Local Control Modality and Outcome for Ewing Sarcoma of the Femur: A Report From the Children's Oncology GroupNajat C Daw, Nadia N Laack, Elizabeth J McIlvaine, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 3, 2014
A research agenda for gender and substance use disorders in the emergency departmentEsther K Choo, Gillian Beauchamp, Francesca L Beaudoin, et al.
Cardio-Oncology (London, England)|March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology GroupLisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
Human Mutation|January 28, 2010
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE studyAke Borg, Robert W Haile, Kathleen E Malone, et al.
International Journal of Radiation Oncology, Biology, Physics|June 17, 2008
Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE studyMarilyn Stovall, Susan A Smith, Bryan M Langholz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
GLIOGENE an International Consortium to Understand Familial GliomaBeatrice Malmer, Phyllis Adatto, Georgina Armstrong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2Kathleen E Malone, Colin B Begg, Robert W Haile, et al.
Journal of the National Cancer Institute|December 27, 2007
Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology StudyLisbeth Bertelsen, Leslie Bernstein, Jørgen H Olsen, et al.
Pageof 109